Throughout the course of a clinical trial, sponsors need to collect strong, repeatable data in order to demonstrate the efficacy and safety of a drug. In trials that rely on patients to take drugs according to a set schedule at home, poor adherence on the part of participants can greatly impact the results. In fact, research from the New England Journal of Medicine shows that only 34 percent of trial participants take medications as prescribed.
While the purpose of a trial is to determine if a drug works as planned and is efficacious, sponsors have not historically had an objective means to tell if a drug is in fact not working or if variable results are due to non-adherence. The good and exciting news is digital health technologies are changing this. Over the last few years, we have seen new, innovative devices and technologies entering the market, including smart pill bottles, connected inhalers and ingestible sensors from device manufacturers that include Proteus Digital Health, AdhereTech and Cohero. Some pharma companies are even creating their own sensors to embed in medications to track adherence. For the full article click here
from health IT caucus http://ift.tt/2aPssSd
via IFTTT
No comments:
Post a Comment